Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study:

Massimo Imazio,Alessandro Andreis,Gaetano M. De Ferrari,Paul Cremer,Vartan Mardigyan,Silvia Maestroni,Sushil A. Luis,Giuseppe Lopalco,Giacomo Emmi,Dor Lotan,Renzo Marcolongo,George Lazaros,Marzia De Biasio,Luca Cantarini,Lorenzo Dagna,Andreja Černe Čerček,Emanuele Pivetta,Beni Varma,Laeora Berkson,Enrico Tombetti,Florenzo Iannone,Domenico Prisco,Alida L.P. Caforio,Dimitrios Vassilopoulos,Dimitrios Tousoulis,Giacomo De Luca,Carla Giustetto,Mauro Rinaldi,Jae K. Oh,Allan L. Klein,Antonio Brucato,Yehuda Adler

Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study:

2019

AimsNovel therapies are needed for recurrent pericarditis, particularly when corticosteroid dependent and colchicine resistant. Based on limited data, interleukin-1 blockade with anakinra may be be...

Keywords:

Physical therapy
Diabetes mellitus
Interleukin 1 receptor antagonist
Anakinra
Corticosteroid
Internal medicine
Blockade
Medicine
Gastroenterology
Colchicine
Pericarditis
recurrent pericarditis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations